Quick Answer
Rallybio Corp reported Operating Income of -$33.06 million for fiscal year 2025.
Rallybio Corp Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$33.06M | +45.3% |
| 2024 | -$60.50M | +23.4% |
| 2023 | -$78.93M | -16.3% |
| 2022 | -$67.88M | -48.7% |
| 2021 | -$45.65M | -80.4% |
| 2020 | -$25.30M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$6.92M | +42.6% | +31.1% |
| June 30, 2025 | -$10.06M | +41.0% | -4.0% |
| March 31, 2025 | -$9.67M | +51.1% | +19.9% |
| September 30, 2024 | -$12.07M | +37.7% | +29.2% |
| June 30, 2024 | -$17.04M | +15.2% | +13.9% |
| March 31, 2024 | -$19.79M | -7.7% | -2.2% |
| September 30, 2023 | -$19.36M | -2.7% | +3.6% |
| June 30, 2023 | -$20.08M | -14.0% | -9.3% |
- Rallybio Corp showed an increase of +45.3% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Rallybio Corp’s operating income has declined by 30.7% (from -$25.30 million to -$33.06 million).
- The most recent figure is from Rallybio Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: